Insights to HIV-1 coreceptor usage by estimating HLA adaptation with Bayesian generalized linear mixed models

PLoS Comput Biol. 2023 Dec 21;19(12):e1010355. doi: 10.1371/journal.pcbi.1010355. eCollection 2023 Dec.

Abstract

The mechanisms triggering the human immunodeficiency virus type I (HIV-1) to switch the coreceptor usage from CCR5 to CXCR4 during the course of infection are not entirely understood. While low CD4+ T cell counts are associated with CXCR4 usage, a predominance of CXCR4 usage with still high CD4+ T cell counts remains puzzling. Here, we explore the hypothesis that viral adaptation to the human leukocyte antigen (HLA) complex, especially to the HLA class II alleles, contributes to the coreceptor switch. To this end, we sequence the viral gag and env protein with corresponding HLA class I and II alleles of a new cohort of 312 treatment-naive, subtype C, chronically-infected HIV-1 patients from South Africa. To estimate HLA adaptation, we develop a novel computational approach using Bayesian generalized linear mixed models (GLMMs). Our model allows to consider the entire HLA repertoire without restricting the model to pre-learned HLA-polymorphisms. In addition, we correct for phylogenetic relatedness of the viruses within the model itself to account for founder effects. Using our model, we observe that CXCR4-using variants are more adapted than CCR5-using variants (p-value = 1.34e-2). Additionally, adapted CCR5-using variants have a significantly lower predicted false positive rate (FPR) by the geno2pheno[coreceptor] tool compared to the non-adapted CCR5-using variants (p-value = 2.21e-2), where a low FPR is associated with CXCR4 usage. Consequently, estimating HLA adaptation can be an asset in predicting not only coreceptor usage, but also an approaching coreceptor switch in CCR5-using variants. We propose the usage of Bayesian GLMMs for modeling virus-host adaptation in general.

MeSH terms

  • Bayes Theorem
  • HIV Infections*
  • HIV-1*
  • Histocompatibility Antigens
  • Humans
  • Phylogeny
  • Receptors, CCR5 / genetics
  • Receptors, CCR5 / metabolism
  • Receptors, CXCR4 / genetics
  • Receptors, CXCR4 / metabolism

Substances

  • Receptors, CCR5
  • Receptors, CXCR4
  • Histocompatibility Antigens

Grants and funding

N.P. was funded by the annual donation in 2016 of the Supporting Members of the Max Planck Society for the project ‘How is the immune system tricked by the HI-virus?’. N.P. was supported by infrastructural funding from the Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections and the DFG Cluster of Excellence ‘Machine Learning|New Perspectives for Science’ (EXC 2064/1, project no. 390727645). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.